97986-34-0

Basic information

• Product Name: Oxan-4-yl 4-methylbenzenesulfonate
• Synonyms: Oxan-4-yl 4-methylbenzenesulfonate;Tetrahydro-2H-pyran-4-yl 4-methylbenzenesulfonate;Tetrahydro-2H-pyran-4-yl p-tosylate;Toluene-4-sulfonicacidtetrahydro-pyran-4-ylester
• CAS NO: 97986-34-0
• Molecular Formula: C₁₂H₁₆O₄S
• Molecular Weight: 256.31804
• Mol File: 97986-34-0.mol
• Article Data: 34

Chemical Properties

• Boiling Point: 398.4±35.0 °C(Predicted)
• Appearance: /
• Density: 1.26±0.1 g/cm3(Predicted)
• Storage Temp.: Room temperature.
• CAS DataBase Reference: Oxan-4-yl 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: Oxan-4-yl 4-methylbenzenesulfonate(97986-34-0)
• EPA Substance Registry System: Oxan-4-yl 4-methylbenzenesulfonate(97986-34-0)

Safety Data

• Hazardous Substances Data: 97986-34-0(Hazardous Substances Data)

Usage

General Description

Oxan-4-yl 4-methylbenzenesulfonate, also known as Mestranol, is a synthetic estrogen that is used in combination with other hormones as a form of birth control. It works by preventing ovulation and changing the cervical mucus to make it more difficult for sperm to reach the egg. Mestranol is considered a prodrug, meaning it is metabolized in the body to form the active hormone ethinyl estradiol. It is typically administered orally and is well absorbed from the gastrointestinal tract. Mestranol has been used in various hormonal contraceptive formulations, but its use has decreased in favor of newer, more effective progestin-estrogen combinations.

Upstream product

• 2081-44-9 Tetrahydro-pyran-4-ol 
• 108-97-4 4-pyrone 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 116312-69-7 tetrahydro-2H-pyran-4-yl-hydrazine 
• 629610-52-2 C₁₄H₁₈O₃ 
• 25637-18-7 4-iodotetrahydropyran 
• 1240042-03-8 4-(4-methoxyphenoxy)-tetrahydro-2H-pyran 
• 894400-98-7 trifluoromethanesulfonic acid 4-[pyrimidin-2-yl-(tetrahydropyran-4-yl)amino]phenyl ester 
• 5337-03-1 tetrahydro-2H-pyran-4-carboxylic acid 
• 233276-38-5 4-methyltetrahydro-2H-pyran-4-carboxylic acid 
• 856255-87-3 4-methyltetrahydro-2H-pyran-4-carbonitrile 

Relevant articles and documents

Fused tricyclic derivative as FGFR4 inhibitor

The present invention provides a fused tricyclic derivative that is the selective inhibitor of fibroblast growth factor receptor 4 (FGFR4), a pharmaceutical composition containing the compound, a method of making the compound and a method of treating cell proliferative diseases, such as cancer, using the compounds of the invention.

2H-INDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

This invention relates to 2H-indazole Derivatives of formula (I'), or pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, capable of modulating the activity of IRAK4. The invention further provides a method of manufacturing compounds of the invention, and methods for their therapeutic use. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including inflammatory disease, autoimmune disease, cancer, cardiovascular disease, a disease of the central nervous system, disease of the skin, an ophthalmic disease and condition, and a bone disease.

CYANO-SUBSTITUTED INDOLE COMPOUNDS AND USES THEREOF AS LSD1 INHIBITORS

A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1) - mediated diseases or disorders: (I) wherein R1, R2, R3, R4, R5, and R6 are as defined herein.